Adjuvanted Epstein-Barr virus glycoprotein 350 vaccine
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Adjuvanted Epstein-Barr virus glycoprotein 350 vaccine, covering 2026-04-22 to 2026-04-22. Get the full timeline:
Most recent: Clinical Trial Update: Trial Evaluating the Immunogenicity and Safety of an Adjuvanted Epstein-Barr Virus (EBV) Glycoprotein 350 Vaccine in EBV-seronegative Persons [Phase 1, Phase 2]